About

Publications While At HealthPartners

selected publications

Journal Article

Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 

JAMA cardiology. 2017

Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. 

Diabetes care. 2014

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. 

Diabetes care. 2012

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. 

Lancet Neurology. 2011

Effects of combination lipid therapy in type 2 diabetes mellitus. 

New England Journal of Medicine. 2010

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol

2007

Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol

2007

presentations

Presentation

Effect of fenofibrate therapy on cardiovascular disease in men vs women with type 2 diabetes in the ACCORD-Lipid Trial [presentation]

Hypertriglyceridemia and low HDL-C predicts fenofribrate response in the ACCORD-Lipid Trial [presentation]

Contact

full name

L. C. Lovato

LC Lovato

Quick Info

 

Collaboration

Co-author network

Map of science